Literature DB >> 32100130

Tumor control of cervical lymph node metastases of unknown primary origin: the impact of the radiotherapy target volume.

Jos M J A A Straetmans1,2, Marijn Stuut3, Sanne Wagemakers3, Frank Hoebers4, Johannes H A M Kaanders5, Ernst Jan M Speel6, Willem J G Melchers7, Piet Slootweg8, Bernd Kremer3, Martin Lacko3, Robert P Takes9.   

Abstract

PURPOSE: Debate on the extent of treatment of neck metastasis of cancer of unknown primary tumors (CUPs) is still ongoing. In two Dutch tertiary referral centers, the post-surgical radiation target volume changed from the bilateral neck including the pharyngeal axis to the unilateral neck only, in the course of the last decade. This study aims to investigate the outcome of patients with CUP before and after de-escalation of post-surgical radiotherapy.
METHODS: Data of two Dutch tertiary referral centers were merged. Disease-free survival (DFS), overall survival (OS), and regional control rate (RCR) of 80 patients diagnosed with CUP (squamous cell and undifferentiated carcinomas) between 1990 and 2009 were retrospectively analyzed.
RESULTS: Thirty patients received bilateral neck and pharyngeal axis radiotherapy and 42 patients ipsilateral radiotherapy only. In another eight patients, the postsurgical radiation target volume was expanded to the contralateral neck or to the pharyngeal axis, due to suspicious lesions on imaging. The 5-year DFS, OS and RCR were 60%, 51.2%, and 80%, respectively, in the total patient population. RCR did not differ in patients treated with ipsilateral as compared to bilateral radiotherapy nor did 5-year OS and DFS. No tumors occurred in the pharyngeal axis.
CONCLUSION: In this study, omitting elective treatment of the contralateral neck and pharyngeal axis did not lead to a decrease in locoregional control or survival rates when treating patients with CUP.

Entities:  

Keywords:  Lymph node; Neck dissection; Neoplasms; Pathology; Radiotherapy; Survival rate; Unknown primary

Mesh:

Year:  2020        PMID: 32100130     DOI: 10.1007/s00405-020-05867-2

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  2 in total

1.  [Diagnosis and treatment of 39 patients with cervical lymph node metastases of squamous cell carcinoma of unknown primary origin, referred to Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, 1979-98].

Authors:  W M Klop; A J Balm; R B Keus; F J Hilgers; I B Tan
Journal:  Ned Tijdschr Geneeskd       Date:  2000-07-08

Review 2.  Optimization of radiotherapy for neck carcinoma metastasis from unknown primary sites: a meta-analysis.

Authors:  Xiaomei Liu; Dianhe Li; Na Li; Xiaoxia Zhu
Journal:  Oncotarget       Date:  2016-11-29
  2 in total
  2 in total

1.  The prognostic role of radiotherapy and radiotherapy target in cervical lymph node metastatic squamous cell carcinoma with unknown primary: a retrospective study.

Authors:  Ruidan Li; Kai Liao; Zhigong Wei; Zheran Liu; Yan He; Jingjing Wang; Ling He; Xiaoli Mu; Lianlian Yang; Yan Huang; Libang He; Xingchen Peng
Journal:  J Cancer Res Clin Oncol       Date:  2021-07-10       Impact factor: 4.553

Review 2.  Metastatic Squamous Cell Carcinoma to the Cervical Lymph Nodes From an Unknown Primary Cancer: Management in the HPV Era.

Authors:  Francisco J Civantos; Jan B Vermorken; Jatin P Shah; Alessandra Rinaldo; Carlos Suárez; Luiz P Kowalski; Juan P Rodrigo; Kerry Olsen; Primoz Strojan; Antti A Mäkitie; Robert P Takes; Remco de Bree; June Corry; Vinidh Paleri; Ashok R Shaha; Dana M Hartl; William Mendenhall; Cesare Piazza; Michael Hinni; K Thomas Robbins; Ng Wai Tong; Alvaro Sanabria; Andres Coca-Pelaz; Johannes A Langendijk; Juan Hernandez-Prera; Alfio Ferlito
Journal:  Front Oncol       Date:  2020-11-10       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.